JP2003531119A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003531119A5 JP2003531119A5 JP2001572528A JP2001572528A JP2003531119A5 JP 2003531119 A5 JP2003531119 A5 JP 2003531119A5 JP 2001572528 A JP2001572528 A JP 2001572528A JP 2001572528 A JP2001572528 A JP 2001572528A JP 2003531119 A5 JP2003531119 A5 JP 2003531119A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- embedded image
- providing
- dimethyl
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C[C@]1(C(CC2)C([C@](*)CC(C3)=C4CCC33OCCO3)C4=CC1)C2O Chemical compound C[C@]1(C(CC2)C([C@](*)CC(C3)=C4CCC33OCCO3)C4=CC1)C2O 0.000 description 4
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19353000P | 2000-03-31 | 2000-03-31 | |
| US60/193,530 | 2000-03-31 | ||
| US19444000P | 2000-04-04 | 2000-04-04 | |
| US60/194,440 | 2000-04-04 | ||
| PCT/US2001/010293 WO2001074839A2 (en) | 2000-03-31 | 2001-03-30 | Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003531119A JP2003531119A (ja) | 2003-10-21 |
| JP2003531119A5 true JP2003531119A5 (enExample) | 2008-05-01 |
| JP4845320B2 JP4845320B2 (ja) | 2011-12-28 |
Family
ID=26889099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001572528A Expired - Fee Related JP4845320B2 (ja) | 2000-03-31 | 2001-03-30 | （７α，１１β）−ジメチル−１７β−ヒドロキシ−４−エストレン−３−オンの４−Ｎ−ブチルシクロヘキサン酸エステル及びウンデカン酸エステルの製造方法及びそれらの医学用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7196074B2 (enExample) |
| EP (1) | EP1272196B1 (enExample) |
| JP (1) | JP4845320B2 (enExample) |
| AT (1) | ATE334682T1 (enExample) |
| AU (2) | AU2001249661B2 (enExample) |
| CA (1) | CA2402524C (enExample) |
| DE (1) | DE60121928T2 (enExample) |
| WO (1) | WO2001074839A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952319A (en) | 1997-11-26 | 1999-09-14 | Research Triangle Institute | Androgenic steroid compounds and a method of making and using the same |
| US20030069215A1 (en) * | 2001-03-30 | 2003-04-10 | The Government Of The United States Of America, | Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate |
| GB0025221D0 (en) * | 2000-10-14 | 2000-11-29 | Astrazeneca Ab | New process |
| JP5227593B2 (ja) * | 2005-02-04 | 2013-07-03 | アメリカ合衆国 | ナンドロロン１７β−カーボネート |
| US20100160275A1 (en) * | 2006-09-26 | 2010-06-24 | Lee Eva Y H P | Methods and compositions for cancer prevention and treatment |
| US9517240B2 (en) | 2006-09-26 | 2016-12-13 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
| BR112014012444B1 (pt) | 2011-11-23 | 2021-12-14 | Therapeuticsmd, Inc | Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10050658B2 (en) | 2014-02-24 | 2018-08-14 | National Products, Inc. | Docking sleeve with electrical adapter |
| CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
| WO2021252761A2 (en) * | 2020-06-11 | 2021-12-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Monomeric and oligomeric compound embodiments as contraceptives and therapies and methods of making and using the same |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3160644A (en) * | 1955-08-08 | 1964-12-08 | Upjohn Co | 1-dehydro-11-keto-9alpha-fluoro-17alpha-methyl testosterones |
| US2837517A (en) * | 1955-08-08 | 1958-06-03 | Upjohn Co | 9, 11beta-epoxy-17-alkyltestosterones |
| US2806863A (en) * | 1956-03-19 | 1957-09-17 | Upjohn Co | 9alpha-halo-11beta, 17beta-dihydroxy-17alpha-methylandrostane-3-ones |
| US3438783A (en) * | 1965-08-16 | 1969-04-15 | Monsanto Co | Improving egg quality in poultry by orally administering androgens |
| US3577410A (en) | 1968-07-30 | 1971-05-04 | American Home Prod | 13beta-alkyl-17-hydroxygona-4,14-dien-3-ones |
| DE2031849C3 (de) | 1970-06-27 | 1978-11-16 | Bosch Gmbh Robert | Flüssigkeitsdichte Verbindung eines Deckels aus thermoplastischem Material mit einem Kasten aus thermoplastischem Material |
| ZA712312B (en) | 1970-04-28 | 1972-01-26 | Ochsner Med Found Alton | 4,14-estradiene compounds |
| IL36628A (en) | 1970-04-28 | 1978-08-31 | Ochsner Med Found Alton | 4, 14-estradiene compounds and processes for their preparation |
| DE3878198T2 (de) * | 1987-12-12 | 1993-06-24 | Akzo Nv | 11-arylsteroid-derivate. |
| FR2747680B1 (fr) * | 1996-04-18 | 1998-07-03 | Roussel Uclaf | Nouveaux steroides, leur application a titre de medicaments, leur procede de preparation, les intermediaires de ce procede et les compositions pharmaceutiques les renfermant |
| DE19619045C1 (de) | 1996-05-02 | 1997-11-13 | Jenapharm Gmbh | Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen |
| US5952319A (en) * | 1997-11-26 | 1999-09-14 | Research Triangle Institute | Androgenic steroid compounds and a method of making and using the same |
| TW548277B (en) | 1999-07-16 | 2003-08-21 | Akzo Nobel Nv | Orally active androgens |
-
2001
- 2001-03-30 EP EP01922911A patent/EP1272196B1/en not_active Expired - Lifetime
- 2001-03-30 AT AT01922911T patent/ATE334682T1/de not_active IP Right Cessation
- 2001-03-30 JP JP2001572528A patent/JP4845320B2/ja not_active Expired - Fee Related
- 2001-03-30 WO PCT/US2001/010293 patent/WO2001074839A2/en not_active Ceased
- 2001-03-30 AU AU2001249661A patent/AU2001249661B2/en not_active Ceased
- 2001-03-30 DE DE60121928T patent/DE60121928T2/de not_active Expired - Lifetime
- 2001-03-30 CA CA002402524A patent/CA2402524C/en not_active Expired - Lifetime
- 2001-03-30 AU AU4966101A patent/AU4966101A/xx active Pending
-
2002
- 2002-10-28 US US10/281,794 patent/US7196074B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003531119A5 (enExample) | ||
| JP3987335B2 (ja) | シス−１−（２−（ヒドロキシメチル）−１，３−オキサチオラン−５−イル）−５−フルオロシトシンのｌ−鏡像体 | |
| JP2848919B2 (ja) | 前更年期のホルモン異常の治療用、更年期のホルモン補充療法用、アンドロゲン誘引性障害の治療用および避妊用医薬 | |
| CA2402524A1 (en) | Methods of making and using 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxy-4-estren-3-one 17.beta.-trans-4-n-butylcyclohexane carboxylate and 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestr-4-en-3-one 17-undecanoate | |
| JP3296564B2 (ja) | 結晶性の〔Ｒ−（Ｒ▲上＊▼，Ｒ▲上＊▼）〕−２−（４−フルオロフェニル）−β，δ−ジヒドロキシ−５−（１−メチルエチル）−３−フェニル−４−〔（フェニルアミノ）カルボニル〕−１Ｈ−ピロール−１−ヘプタン酸ヘミカルシウム塩（アトルバスタチン） | |
| JP2003501474A5 (enExample) | ||
| JP2004509061A5 (enExample) | ||
| JP2003509349A5 (enExample) | ||
| TW518339B (en) | 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives | |
| KR970010784A (ko) | 11-(치환된 페닐)-에스트라-4,9-디엔 유도체 | |
| RU2001119054A (ru) | Калиевая соль (S)-омепразола | |
| JP2002535401A5 (enExample) | ||
| JP2003521471A5 (enExample) | ||
| YU17700A (sh) | Oralne kompozicije levosimendana | |
| JP2008512426A5 (enExample) | ||
| JP2003502367A5 (enExample) | ||
| JP2001524525A5 (enExample) | ||
| JP2005516898A5 (enExample) | ||
| RU2331425C2 (ru) | Фармацевтические композиции и способы, включающие комбинации производных 2-алкилиден-19-нор-витамина d и агониста/антагониста эстрогенов | |
| ES2397996T3 (es) | Derivado de 17beta-ciano-19-nor-androst-4-eno, su utilización y medicamentos que contienen este derivado | |
| JP2002509154A5 (enExample) | ||
| JP2004538278A5 (enExample) | ||
| JP2003521457A5 (enExample) | ||
| NO20061018L (no) | Nytt preparat | |
| JP2002523458A5 (enExample) |